Personalized medicine is the answer for cancer patients who have repeatedly failed conventional treatment and now require tailored treatments suited to their cancer sub-type. Understanding what mutations (quality) and the the load of specific mutations (quantity) can guide the immunotherapist to apply one or a combination of immunotherapeutic strategies.

Having access to digital databases on human tumors and algorithms that can effectively model characteristics and drug response patterns can ultimately inform on the next course of treatment. So digital pathology, tissue informatics (phenomics), drug MOA, combination regimens must all be integrated to bring together effective treatment options. Institute for Systems Biology, Integrative Medicine at MDACC, ICAHN center, Broad Institute, Parker Institute, Stanford and Berkeley are already making important strides.

Not only for dance patients. It is a powerful tool for achieving safer and more effective medication treatments for a wide range of condition, including mental health, cardiovascular health., digestive disorders, pain etc.
In fact, Clinical Pharmacogenegtics Implementation Consortium curates and publishes detailed guidelines for over 200 top prescribed medications. It has been implemented (outside of cancer care) by many clinical organizations in US: University of Florida, Vanderbilt, Mayo clinic.
Our company, GeneYouIn, developed Pillcheck digital health platform (www.pillcheck.ca) to ensure that personalized medicine can be practiced in any setting, not only within the walls of the major research hospitals.